Back
Entrada Therapeutics Stock Price Chart
Sponsored
TRDA
Sponsored
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
TRDA
Entrada Therapeutics
Last Price:
17.08
Seasonality Move:
6.92%
7 Day Trial
ALL ACCESS PASS
$
7
Invest in This AI Tech Innovator Doubling Revenue
Invest Now!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight buying pressure.
Entrada Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.93 | Buy |
20-day SMA: | 15.16 | Buy |
50-day SMA: | 15.65 | Buy |
200-day SMA: | 14.78 | Buy |
8-day EMA: | 15.92 | Buy |
20-day EMA: | 15.59 | Buy |
50-day EMA: | 15.56 | Buy |
200-day EMA: | 15.05 | Buy |
Entrada Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 57.88 | Buy |
Chaikin Money Flow: | 37888 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.46 - 16.34) | Buy |
Bollinger Bands (100): | (14.55 - 16.63) | Buy |
Entrada Therapeutics Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Entrada Therapeutics Stock
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 16.44 while TRDA 8-day simple moving average is 15.93, which is a Buy signal.
- The stock price of TRDA is 16.44 while Entrada Therapeutics 20-day SMA is 15.16, which makes it a Buy.
- Entrada Therapeutics 50-day simple moving average is 15.65 while TRDA share price is 16.44, making it a Buy technically.
- TRDA stock price is 16.44 and Entrada Therapeutics 200-day simple moving average is 14.78, creating a Buy signal.
TRDA Technical Analysis vs Fundamental Analysis
Buy
55
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy or a Sell?
-
Entrada Therapeutics stock is rated a Buy
The current Entrada Therapeutics [TRDA] share price is $16.44. The Score for TRDA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Entrada Therapeutics Stock Info
Market Cap:
611.56M
Price in USD:
16.44
Share Volume:
142.81K
Entrada Therapeutics 52-Week Range
52-Week High:
18.17
52-Week Low:
10.75
Buy
55
Entrada Therapeutics (TRDA)
is a Buy
Entrada Therapeutics Share Price Forecast
-
What is the Entrada Therapeutics stock price today?
The Entrada Therapeutics stock price is 16.44 USD today. -
Will TRDA stock go up or go down?
Entrada Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Entrada Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics is not overvalued.
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 16.44 while TRDA 8-day exponential moving average is 15.92, which is a Buy signal.
- The stock price of TRDA is 16.44 while Entrada Therapeutics 20-day EMA is 15.59, which makes it a Buy.
- Entrada Therapeutics 50-day exponential moving average is 15.56 while TRDA share price is 16.44, making it a Buy technically.
- TRDA stock price is 16.44 and Entrada Therapeutics 200-day simple moving average is 15.05, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics
Is Entrada Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
Technical Analysis of Entrada Therapeutics
Should I short Entrada Therapeutics stock?
- TRDA Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Entrada Therapeutics is a Buy
- Entrada Therapeutics Relative Strength Index (RSI) is 57.88, which suggest Entrada Therapeutics is overbought
- The Bollinger Bands (25) for Entrada Therapeutics is (14.46 - 16.34), which suggest Entrada Therapeutics is a Buy
- The Bollinger Bands (100) for Entrada Therapeutics is (14.55 - 16.63), which suggest Entrada Therapeutics is a Buy
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.